Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters
Language
Publication year range
1.
Intertrigo-like eruption caused by pegylated liposomal doxorubicin (PLD)
Sánchez Henarejos, P; Ros Martínez, S; Marín Zafra, G. R; Alonso Romero, J. L; Navarrete Montoya, A.
Clin. transl. oncol. (Print) ; 11(7): 486-487, jul. 2009. ilus
Article in English | IBECS (Spain) | ID: ibc-123664

ABSTRACT

Pegylated liposomal doxorubicin (PLD) is a drug whose use is increasingly common. It has been associated with a lower rate of haematologic and cardiac side effects than its nonencapsulated form. However, mucocutaneous toxicity is quite frequent and can be severe. Here we provide a case report of a patient who developed an intertrigolike eruption during treatment with PLD (AU)


Subject(s)
Humans , Female , Adult , Antineoplastic Agents/adverse effects , Doxorubicin/analogs & derivatives , Drug Eruptions/complications , Drug Eruptions/pathology , Intertrigo/chemically induced , Intertrigo/pathology , Polyethylene Glycols/adverse effects , Breast Neoplasms/drug therapy , Breast Neoplasms/etiology , Doxorubicin/administration & dosage , Doxorubicin/adverse effects , Neoplasm Metastasis , Neoplasm Recurrence, Local/complications , Neoplasm Staging , Polyethylene Glycols/administration & dosage
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL